Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ormat Technologies | ORA | Nov 25, 2024 | 82.02 | +1.59 |
Orrstown Financial Services | ORRF | Nov 25, 2024 | 40.10 | -0.96 |
Orthofix Medical | OFIX | Nov 25, 2024 | 19.04 | +0.69 |
OrthoPediatrics | KIDS | Nov 25, 2024 | 26.61 | +1.03 |
Oruka Therapeutics | ORKA | Nov 25, 2024 | 18.51 | 0.00 |
OS Therapies | OSTX | Nov 25, 2024 | 2.05 | +5.03 |
Oscar Health A | OSCR | Nov 25, 2024 | 16.85 | +5.44 |
Oshkosh | OSK | Nov 25, 2024 | 114.14 | +2.08 |
OSI Systems | OSIS | Nov 25, 2024 | 168.99 | +2.47 |
Osisko Development | ODV | Nov 25, 2024 | 1.75 | -4.89 |
Osisko Gold Royalties | OR | Nov 25, 2024 | 19.30 | -4.03 |
Ostin Technology Group | OST | Nov 25, 2024 | 0.21 | -3.47 |
Otis Worldwide | OTIS | Nov 25, 2024 | 102.46 | +1.25 |
Otter Tail | OTTR | Nov 25, 2024 | 81.94 | +1.44 |
Ouster | OUST | Nov 25, 2024 | 9.88 | +3.67 |
Outbrain | OB | Nov 25, 2024 | 5.20 | +2.97 |
Outfront Media | OUT | Nov 25, 2024 | 19.36 | +1.20 |
Outlook Therapeutics | OTLK | Nov 25, 2024 | 4.93 | -1.99 |
Outset Medical | OM | Nov 25, 2024 | 0.90 | +7.96 |
Ovid Therapeutics | OVID | Nov 25, 2024 | 1.10 | +4.76 |
Ovintiv | OVV | Nov 25, 2024 | 45.75 | -2.06 |
Owens & Minor | OMI | Nov 25, 2024 | 13.65 | +10.53 |
Owens Corning | OC | Nov 25, 2024 | 210.81 | +3.97 |
Owlet A | OWLT | Nov 25, 2024 | 4.60 | -0.43 |
Oxbridge Re | OXBR | Nov 25, 2024 | 3.08 | +0.98 |
Oxford Industries | OXM | Nov 25, 2024 | 81.75 | +5.08 |
Oxford Lane Capital | OXLC | Nov 25, 2024 | 5.22 | 0.00 |
Oxford Lane Capital 2027 Pref | OXLCP | Nov 25, 2024 | 24.07 | -0.06 |
Oxford Square Capital | OXSQ | Nov 25, 2024 | 2.67 | +1.91 |
P.A.M. Transportation Services | PTSI | Nov 25, 2024 | 19.72 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.